Corporate Responsibility Report

Overview

The report describes GSK's 2005 access-to-medicines programmes, including shipment of 126.3 million preferentially priced Combivir and Epivir tablets. It also reproduces ERM's external verification of the environment and health and safety reporting. Environmental performance included 19.2 million gigajoules of energy consumption and 21.7 million cubic metres of water consumption, while one employee and two members of the public died in work-related driving incidents.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2005
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis

Assurance

Provider
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services